BIO 是一个面向去中心化科学(DeSci)的策展和流动性协议。我们的使命是通过赋予全球患者、科学家和生物技术专业人士共同资助、构建和拥有生物技术项目和知识产权(IP)的能力,从而加速生物技术的发展。
BIO 背后的团队帮助创建了 Molecule,这是一个面向早期生物医学的代币化平台,以及 VitaDAO,这是最大的去中心化长寿科学社区。在这些成功的基础上,BIO 被设计用来通过去中心化的资金、激励和流动性来推动链上的科学经济。
BIO 代币让持有者能够访问 BIO 的科学社区网络和知识产权,从而广泛参与 DeSci 经济。
Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for BIO. Our analysts highlight strong fundamentals and favorable market sentiment, positioning BIO for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: BIO is a Strong Buy candidate.
BIO price ended at $0.040015 on 星期三, after rising 21.35%
On Apr 29, 2026 00:00, the price of BIO rose by 21.35%, climbing from $0.028030 to $0.040015 with 24h trading volume reaching $279.9M BIO.